BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 18607832)

  • 21. Immunohistochemical and genetic profiles of endometrioid endometrial carcinoma arising from atrophic endometrium.
    Geels YP; van der Putten LJ; van Tilborg AA; Lurkin I; Zwarthoff EC; Pijnenborg JM; van den Berg-van Erp SH; Snijders MP; Bulten J; Visscher DW; Dowdy SC; Massuger LF
    Gynecol Oncol; 2015 May; 137(2):245-51. PubMed ID: 25773202
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential expression of clusterin according to histological type of endometrial carcinoma.
    Ahn HJ; Bae J; Lee S; Ko JE; Yoon S; Kim SJ; Sakuragi N
    Gynecol Oncol; 2008 Aug; 110(2):222-9. PubMed ID: 18514801
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endometrial TIMP-4 mRNA is high at midcycle and in hyperplasia, but down-regulated in malignant tumours. Coordinated expression with MMP-26.
    Pilka R; Domanski H; Hansson S; Eriksson P; Casslén B
    Mol Hum Reprod; 2004 Sep; 10(9):641-50. PubMed ID: 15273280
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunohistochemical expression of epidermal growth factor receptor, E-cadherin, and matrix metalloproteinase-9 in ovarian epithelial cancer and relation to patient deaths.
    Alshenawy HA
    Ann Diagn Pathol; 2010 Dec; 14(6):387-95. PubMed ID: 21074685
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum response factor enhances liver metastasis of colorectal carcinoma via alteration of the E-cadherin/beta-catenin complex.
    Choi HN; Kim KR; Lee JH; Park HS; Jang KY; Chung MJ; Hwang SE; Yu HC; Moon WS
    Oncol Rep; 2009 Jan; 21(1):57-63. PubMed ID: 19082443
    [TBL] [Abstract][Full Text] [Related]  

  • 26. E-cadherin, beta-catenin adhesion complex and relation to matrilysin expression in pT3 rectosigmoid cancers.
    Dilek FH; Topak N; Aktepe F; Sahin O; Türel KS; Sahin DA; Dilek ON
    Pathol Res Pract; 2008; 204(11):809-15. PubMed ID: 18674869
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Expression of beta-catenin, Glut-1, PTEN proteins in uterine endometrioid adenocarcinoma and its precursor lesions].
    Xiong Y; Xiong YY; Zhou YF
    Zhonghua Bing Li Xue Za Zhi; 2009 Sep; 38(9):594-9. PubMed ID: 20079187
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Correlation of vasculogenic mimicry with clinicopathologic features and prognosis of ovarian carcinoma].
    Gao Y; Zhao XL; Gu Q; Wang JY; Zhang SW; Zhang DF; Wang XH; Zhao N; Gao YT; Sun BC
    Zhonghua Bing Li Xue Za Zhi; 2009 Sep; 38(9):585-9. PubMed ID: 20079185
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MMP-9 and -12 cause N-cadherin shedding and thereby beta-catenin signalling and vascular smooth muscle cell proliferation.
    Dwivedi A; Slater SC; George SJ
    Cardiovasc Res; 2009 Jan; 81(1):178-86. PubMed ID: 18852254
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunohistochemical analysis of the progression of flat and papillary preneoplastic lesions in intrahepatic cholangiocarcinogenesis in hepatolithiasis.
    Itatsu K; Zen Y; Ohira S; Ishikawa A; Sato Y; Harada K; Ikeda H; Sasaki M; Nimura Y; Nakanuma Y
    Liver Int; 2007 Nov; 27(9):1174-84. PubMed ID: 17919228
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Loss of E-cadherin and cytoplasmic-nuclear expression of beta-catenin are the most useful immunoprofiles in the diagnosis of solid-pseudopapillary neoplasm of the pancreas.
    Kim MJ; Jang SJ; Yu E
    Hum Pathol; 2008 Feb; 39(2):251-8. PubMed ID: 17959228
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aberrant expression of E-cadherin and beta-catenin in human prostate cancer.
    Jaggi M; Johansson SL; Baker JJ; Smith LM; Galich A; Balaji KC
    Urol Oncol; 2005; 23(6):402-6. PubMed ID: 16301117
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Up-regulation of ERM/ETV5 correlates with the degree of myometrial infiltration in endometrioid endometrial carcinoma.
    Planagumà J; Abal M; Gil-Moreno A; Díaz-Fuertes M; Monge M; García A; Baró T; Xercavins J; Reventós J; Alameda F
    J Pathol; 2005 Dec; 207(4):422-9. PubMed ID: 16175655
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nuclear morphometry as an adjunct to cytopathologic examination of endometrial brushings on LBC samples: A prospective approach to combined evaluation in endometrial neoplasms and look alikes.
    Norimatsu Y; Irino S; Maeda Y; Yanoh K; Kurokawa T; Hirai Y; Kobayashi TK; Fulciniti F
    Cytopathology; 2021 Jan; 32(1):65-74. PubMed ID: 32794283
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cyclin D1 expression in endometrioid-type endometrial adenocarcinoma is correlated with histological grade and proliferative activity, but not with prognosis.
    Nishimura Y; Watanabe J; Jobo T; Kato N; Fujisawa T; Kamata Y; Kuramoto H
    Anticancer Res; 2004; 24(4):2185-91. PubMed ID: 15330159
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Contribution of immunohistochemistry and flow-cytometry in the study of endometrial pathology].
    Amălinei C; Căruntu ID; Balan R; Cianga C; Cianga P
    Rev Med Chir Soc Med Nat Iasi; 2008; 112(2):437-48. PubMed ID: 19295017
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IMP2 expression distinguishes endometrioid from serous endometrial adenocarcinomas.
    Zhang L; Liu Y; Hao S; Woda BA; Lu D
    Am J Surg Pathol; 2011 Jun; 35(6):868-72. PubMed ID: 21566514
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effect of carbon dioxide pneumoperitoneum-laparoscopic surgery on tumor seeding and metastases in endometrial cancer].
    Fu C; Li GY; Liu FY; Lin QH; Fang XL
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Feb; 33(2):130-7. PubMed ID: 18326907
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic value of matrix metalloproteinase-2 (MMP-2) expression in endometrial endometrioid adenocarcinoma.
    Talvensaari-Mattila A; Santala M; Soini Y; Turpeenniemi-Hujanen T
    Anticancer Res; 2005; 25(6B):4101-5. PubMed ID: 16309203
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of matrix metalloproteinase-26 and tissue inhibitors of metalloproteinases TIMP-3 and -4 in benign endometrium and endometrial cancer.
    Tunuguntla R; Ripley D; Sang QX; Chegini N
    Gynecol Oncol; 2003 Jun; 89(3):453-9. PubMed ID: 12798711
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.